On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Sistemic Scotland Limited's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€596k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- REGENER-ARPartner
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis
FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗
€596ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
- Centro de Investigaciones Energeticas Medioambientales y TecnologicasSpain · 1 shared project
- Zabala Innovation Consulting SASpain · 1 shared project
- Mondragon Assembly Sociedad CooperativaSpain · 1 shared project
- Tigenix SASpain · 1 shared project
- Tigenix NVBelgium · 1 shared project
- Farma-Cros Iberica S.l.Spain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- pharmaceutical drugs
- rheumatology
- stem cells
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗